Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma.
Saved in:
| Title: | Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma. |
|---|---|
| Authors: | Hornsteiner F; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Vierthaler J; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Strandt H; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Resag A; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Germany., Fu Z; Malaghan Institute of Medical Research, Wellington, New Zealand., Ausserhofer M; Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria., Tripp CH; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Dieckmann S; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Kanduth M; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Farrand K; Malaghan Institute of Medical Research, Wellington, New Zealand., Bregar S; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Nemati N; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Hermann-Kleiter N; Institute of Cell Genetics, Department for Genetics and Pharmacology, Medical University of Innsbruck, Innsbruck, Austria., Seretis A; Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria., Morla S; Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria., Mullins D; Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA., Finotello F; Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria., Trajanoski Z; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Wollmann G; Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria., Ronchese F; Malaghan Institute of Medical Research, Wellington, New Zealand., Schmitz M; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Germany., Hermans IF; Malaghan Institute of Medical Research, Wellington, New Zealand., Stoitzner P; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria patrizia.stoitzner@i-med.ac.at. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Apr 17; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38631706 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hornsteiner+F%22">Hornsteiner F</searchLink>; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Vierthaler+J%22">Vierthaler J</searchLink>; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Strandt+H%22">Strandt H</searchLink>; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Resag+A%22">Resag A</searchLink>; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Fu+Z%22">Fu Z</searchLink>; Malaghan Institute of Medical Research, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Ausserhofer+M%22">Ausserhofer M</searchLink>; Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Tripp+CH%22">Tripp CH</searchLink>; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Dieckmann+S%22">Dieckmann S</searchLink>; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Kanduth+M%22">Kanduth M</searchLink>; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Farrand+K%22">Farrand K</searchLink>; Malaghan Institute of Medical Research, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Bregar+S%22">Bregar S</searchLink>; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Nemati+N%22">Nemati N</searchLink>; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Hermann-Kleiter+N%22">Hermann-Kleiter N</searchLink>; Institute of Cell Genetics, Department for Genetics and Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Seretis+A%22">Seretis A</searchLink>; Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Morla+S%22">Morla S</searchLink>; Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Mullins+D%22">Mullins D</searchLink>; Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.<br /><searchLink fieldCode="AU" term="%22Finotello+F%22">Finotello F</searchLink>; Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Trajanoski+Z%22">Trajanoski Z</searchLink>; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Wollmann+G%22">Wollmann G</searchLink>; Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Ronchese+F%22">Ronchese F</searchLink>; Malaghan Institute of Medical Research, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Schmitz+M%22">Schmitz M</searchLink>; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Hermans+IF%22">Hermans IF</searchLink>; Malaghan Institute of Medical Research, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Stoitzner+P%22">Stoitzner P</searchLink>; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria patrizia.stoitzner@i-med.ac.at. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2024 Apr 17; Vol. 12 (4). <i>Date of Electronic Publication: </i>2024 Apr 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38631706 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/jitc-2023-008606 Languages: – Code: eng Text: English Titles: – TitleFull: Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hornsteiner F – PersonEntity: Name: NameFull: Vierthaler J – PersonEntity: Name: NameFull: Strandt H – PersonEntity: Name: NameFull: Resag A – PersonEntity: Name: NameFull: Fu Z – PersonEntity: Name: NameFull: Ausserhofer M – PersonEntity: Name: NameFull: Tripp CH – PersonEntity: Name: NameFull: Dieckmann S – PersonEntity: Name: NameFull: Kanduth M – PersonEntity: Name: NameFull: Farrand K – PersonEntity: Name: NameFull: Bregar S – PersonEntity: Name: NameFull: Nemati N – PersonEntity: Name: NameFull: Hermann-Kleiter N – PersonEntity: Name: NameFull: Seretis A – PersonEntity: Name: NameFull: Morla S – PersonEntity: Name: NameFull: Mullins D – PersonEntity: Name: NameFull: Finotello F – PersonEntity: Name: NameFull: Trajanoski Z – PersonEntity: Name: NameFull: Wollmann G – PersonEntity: Name: NameFull: Ronchese F – PersonEntity: Name: NameFull: Schmitz M – PersonEntity: Name: NameFull: Hermans IF – PersonEntity: Name: NameFull: Stoitzner P IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 04 Text: 2024 Apr 17 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2051-1426 Numbering: – Type: volume Value: 12 – Type: issue Value: 4 Titles: – TitleFull: Journal for immunotherapy of cancer Type: main |
| ResultId | 1 |